A Earnings Prediction
The chart below shows how A performed 10 days before and after its earnings report, based on data from the past quarters. Typically, A sees a -0.09% change in stock price 10 days leading up to the earnings, and a +0.43% change 10 days following the report. On the earnings day itself, the stock moves by -0.19%. This data can give you a slight idea of what to expect for the next quarter's release.
A Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
1.68B
1.39%
-1.18%
Gross Margin
53.48%
-2.34%
-0.80%
Operating Margin
22.43%
-3.90%
-7.62%
Net Margin
18.92%
-9.86%
-8.29%
EPS
1.11
-5.93%
-9.76%
No Data Available
A Earnings Analysis
Agilent Technologies Inc Corporation (A.N) Earnings Conference Call
Positive
Core Revenue Growth Exceeds Expectations: Agilent exceeded expectations for core revenue growth and EPS in Q1 2025, with revenue of $1.681 billion, a 1% increase year-over-year.
Food Market Growth: The company reported strong growth in the Food market, which grew 9% driven by success in capturing stimulus orders in China.
Positive Market Recovery: Agilent's instrument book-to-bill ratio was greater than one in Q1, indicating a positive market recovery and strong customer focus.
Infinity III Series Adoption: The Infinity III series has seen great adoption, with customers appreciating its advanced automation and backward compatibility, leading to significant upgrade opportunities.
Life Sciences Market Growth: The Life Sciences and Diagnostics Markets Group reported a 1% growth, driven by high-single-digit growth in LC and LCMS instruments following the Infinity III launch.
CrossLab Group Growth: The Agilent CrossLab Group grew 3%, led by services, with positive responses to their InfinityLab Assist automation software and OpenLab CDS.
PFAS Testing Solutions Growth: PFAS testing solutions saw a remarkable 70% growth in Q1, contributing significantly to overall company growth.
Strong Financial Position: Agilent's strong balance sheet and cash flow were highlighted, with operating cash flow of $431 million and a net leverage ratio of 1.0.
Global Lighthouse Recognition: The company was recognized by the World Economic Forum for its manufacturing sites in Shanghai and Penang as Global Lighthouse Networks, showcasing its advancements in technology and sustainability.
Sustainability Recognition: Agilent was ranked No. 10 on Newsweek's 2025 list of America’s Most Responsible Companies, reflecting its commitment to sustainability and positive global impact.
Negative
Below Target Revenue Growth: Revenue growth was only 1% year-over-year, which is below the company's target growth rate of 5% to 7%.
Revenue Decline Challenges: The Applied Markets Group reported a 2% decline in revenue, indicating challenges in that segment despite strong performance in China.
Gross Margin Decline: Gross margin decreased to 54.7%, down from the previous year, primarily due to unfavorable product mix and currency impacts.
Conservative Growth Guidance: The company is maintaining a conservative core growth guidance of 2.5% to 3.5% for the year, reflecting uncertainty in the U.S. federal funding environment.
Currency Impact Forecast: Currency fluctuations are expected to have a significant negative impact, with an estimated 1.9% headwind for the year, which is higher than previously anticipated.
Market Segment Decline: The Academia and Government market, which is the smallest segment, saw a decline of 7%, indicating weakness in that area.
A FAQs
How does A typically perform around its earnings report dates?
Is Agilent Technologies Inc (A) Q1 2025 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
A Earning Call Sentiment
Agilent Technologies, Inc. (A) Q1 2025 Earnings Call Transcript
A.N
1.7%Positive
The earnings call presents a mixed picture. Basic financial performance shows slight growth, but with challenges in margins and currency impacts. Product development is promising with strong demand in PFAS and successful launches, yet competitive pressures remain. Market strategy is cautious with prudent guidance amid economic headwinds. Financial health is stable, with share repurchases and dividends, but regulatory and supply chain risks persist. The Q&A reveals uncertainties in headline risks and stimulus impacts. Overall, the sentiment is neutral, with no major catalysts for a strong price movement.
